Phase 3Not yet recruitingINTERVENTIONAL
SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
ClinicalTrials.gov · NCT07855900 · Registry updated: 2026-10-02
- Condition / research focus
- Obesity
- Sponsor
- Boehringer Ingelheim
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2026-11-07. Completion: 2028-06-25 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Survodutide (combination_product) — also listed as: BI 456906
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Covenant Metabolic Specialist, LLC - Riverview
Riverview, Florida, United States
Site recruitment: Not reported